Rossmax International Ltd

Rossmax International Ltd

4121 · TWO · Healthcare / Medical Devices

12.25TWD+0.05 (+0.41%)

Price History

Full chart

Market Stats

Previous Close12.20
Open12.05
Day Range12.05 – 12.25
52-Week Range12.55 – 20.85
Volume42.66K
Market Cap1.07B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.49
Dividend Yield0.00%
Beta0.40
50-Day Avg12.91
200-Day Avg14.96

About

Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds of an animal or human body; pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers used to measure human body temperature; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication in the form of a mist; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pads used for therapy; and anti-decubitus mattresses, as well as provides breast pumps. In addition, the company operates Rossmax healthstyle app, which allows customers to monitor blood pressure, blood glucose, SpO2, weight, and temperature through a single app. It provides healthcare products in the fields of cardiovascular, diabetes, respiratory, fever, and wound healing diseases, as well as thermometers, scales, and nebulizers fo. The company also exports its products. It operates in Taiwan, America, Europe, East Asia, South Asia, India, Middle East, Africa, and internationally. Rossmax International Ltd. was founded in 1988 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Chih-Ping Liu
  • Employees0
  • HeadquartersNo. 189, Kang Chien Road, Taipei, Taiwan, 114, Taiwan
  • Websitehttps://www.rossmax.com

Leadership

  • Mr. Chih-Ping LiuChairman of the Board & GM
  • Ms. Cherry ChangDeputy GM of Finance Dept., & Corporate Governance Supervisor
  • Mr. Gary HungR&D Associate Manager
  • Ms. Yolanda LinProduct and Quality Department Associate Manager
  • Mr. Chuan ying WangR&D Associate Manager
  • C. D. LeeSales Manager
  • Mr. Kuan Yu ChuVice President and Associate Manager
  • Mr. Adeb TsaoVP & Associate Manager
  • Mr. Bill WangSpecial Assistant

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.15B3.10B3.09B3.68B3.95B4.34B3.81B3.85B3.80B
Growth (%)--1.79%-0.10%+18.91%+7.31%+10.06%-12.33%+1.11%-1.34%
Cost of Revenue2.19B2.14B2.11B2.45B2.65B2.84B2.54B2.52B2.49B
Gross Profit963.49M954.85M983.14M1.23B1.30B1.51B1.27B1.33B1.31B
Gross Margin30.55%30.83%31.78%33.54%32.84%34.67%33.42%34.65%34.38%
Operating Expense948.26M962.44M984.61M1.03B1.12B1.21B1.23B1.41B1.38B
Operating Income15.23M-7.59M-1.46M200.93M181.46M297.83M39.08M-76.74M-72.38M
Operating Margin0.48%-0.25%-0.05%5.46%4.60%6.85%1.03%-1.99%-1.91%
EBITDA119.35M100.30M276.95M429.58M425.88M581.56M345.23M307.86M307.83M
EBITDA Margin3.78%3.24%8.95%11.68%10.79%13.38%9.06%7.99%8.10%
Net Income27.67M16.59M25.73M135.46M111.37M170.27M-6.67M-29.35M-29.90M
Net Income Margin0.88%0.54%0.83%3.68%2.82%3.92%-0.17%-0.76%-0.79%
R&D40.60M43.06M64.38M58.87M55.78M53.77M50.90M51.62M53.28M
R&D as % of Total Revenue1.29%1.39%2.08%1.60%1.41%1.24%1.34%1.34%1.40%
Interest Expense09.62M22.13M21.73M19.83M22.98M25.37M30.21M27.83M
Interest Expense % of Total Revenue0.00%0.31%0.72%0.59%0.50%0.53%0.67%0.78%0.73%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.41B2.30B3.06B3.36B3.76B3.99B4.09B4.23B4.21B
Total Liabilities1.06B958.00M1.73B1.70B1.98B2.05B2.24B2.14B2.22B
Total Equity1.14B1.12B1.12B1.34B1.45B1.55B1.44B1.48B1.41B
Cash538.79M409.33M28.55M537.23M608.46M510.71M482.90M594.26M613.70M
Total Debt---936.71M1.08B1.12B1.39B--
Net Debt---28.55M399.48M471.10M614.01M904.96M--

Cash Flow

Currency: TWD2003-12-312007-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---97.57M23.56M81.95M459.35M575.43M434.21M302.35M314.10M284.20M
Investing Cash Flow---30.83M-48.09M-22.11M-81.97M-347.69M-137.20M---
Financing Cash Flow--164.73M-103.84M-12.82M-295.21M-150.60M-396.22M-216.34M--
Capital Expenditure0038.64M46.45M41.46M81.61M349.83M134.66M107.35M75.56M47.46M
Free Cash Flow---138.13M-32.06M39.68M377.73M225.60M299.54M195.01M238.54M236.74M
Dividends Paid--21.87M21.87M7.33M14.66M95.18M92.75M101.92M48.78M-
FCF to OCF--141.57%-136.04%48.42%82.23%39.21%68.99%64.50%75.94%83.30%
Dividend Paid to FCF---15.83%-68.21%18.48%3.88%42.19%30.97%52.26%20.45%-

Earnings

Report DateAug 29, 2007Jan 22, 2008Apr 28, 2008Jun 30, 2008Oct 30, 2008Dec 31, 2008Apr 3, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010May 8, 2011Aug 26, 2011Oct 8, 2011Dec 31, 2011May 8, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate0.520.560.28-0.450.350.35--------------------------------------------------------
EPS Actual0.480.200.21-0.140.04-0.62-0.62-0.090.190.570.170.360.500.410.190.21-0.040.060.080.030.27-0.030.55-0.13-0.10-0.150.03-0.02-0.03-0.02-0.12-0.080.14-0.32-0.08-0.22-0.090.66-0.390.290.360.120.000.160.08-0.020.070.050.060.160.250.340.770.430.320.780.170.050.220.950.560.280.11
Surprise-7.69%-64.29%-25.00%--91.11%-277.70%-277.14%--------------------------------------------------------
TimingAfter-hoursAfter-hoursPre-market-Pre-market-Pre-market-------After-hoursPre-marketAfter-hours-After-hours--------------------------------------------

Key Statistics & Ratios

Market Cap1.07B
Enterprise Value1.62B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.28
Price / Book0.76
EPS-0.49
Book Value17.08
Revenue (TTM)3.78B
Gross Profit (TTM)1.28B
EBITDA-20.18M
Profit Margin-1.07%
Operating Margin-2.74%
Return on Equity-4.14%
Return on Assets-1.54%
Shares Outstanding83.11M
Shares Float52.82M
Beta0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.50Jun 12, 2024
20231×
1.20Jun 19, 2023
20221×
1.09Jul 20, 2022
20211×
1.13Aug 30, 2021
20201×
0.20Jun 29, 2020
20191×
0.10Aug 27, 2019
20181×
0.30Jun 13, 2018
20131×
0.20Jul 11, 2013
20111×
0.40Aug 10, 2011
20081×
0.83Aug 20, 2008

Stock Splits

  • Aug 10, 20111.04:1
  • Jun 15, 20101050:1000
  • Aug 11, 2009105:100
  • Aug 20, 2008102.518:100